| Previous close | 30.89 |
| Open | 28.79 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 28.18 - 28.79 |
| 52-week range | 28.18 - 28.79 |
| Volume | 150 |
| Avg. volume | N/A |
| Market cap | 1.565B |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -9.95 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Newsflash: bluebird bio, Inc. (NASDAQ:BLUE) Analysts Have Been Trimming Their Revenue Forecasts
Market forces rained on the parade of bluebird bio, Inc. ( NASDAQ:BLUE ) shareholders today, when the analysts...
- Business Wire
Breaking Notice: Rosen, a Globally Recognized Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – BLUE
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020, inclusive (the "Class Period") of the important April 13, 2021 lead plaintiff deadline.
- Business Wire
bluebird bio to Present at Cowen Health Care Conference
bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Cowen 41st Annual Health Care Conference, Wednesday, March 3, at 2:40 p.m. ET.
© 2021 Verizon Media. All rights reserved.
